Display options
Cite
Bahl NE, Magnavita ES, Hshieh T, et al. Objective performance tests of cognition and physical function as part of a virtual geriatric assessment. J Geriatr Oncol. 2021;12(8):1256-1258doi: 10.1016/j.jgo.2021.03.013.
Bahl, N. E., Magnavita, E. S., Hshieh, T., Testa, M., Kim, D., Manor, B., Driver, J. A., Abel, G. A., & DuMontier, C. (2021). Objective performance tests of cognition and physical function as part of a virtual geriatric assessment. Journal of geriatric oncology, 12(8), 1256-1258. https://doi.org/10.1016/j.jgo.2021.03.013
Bahl, Nupur E, et al. "Objective performance tests of cognition and physical function as part of a virtual geriatric assessment." Journal of geriatric oncology vol. 12,8 (2021): 1256-1258. doi: https://doi.org/10.1016/j.jgo.2021.03.013
Bahl NE, Magnavita ES, Hshieh T, Testa M, Kim D, Manor B, Driver JA, Abel GA, DuMontier C. Objective performance tests of cognition and physical function as part of a virtual geriatric assessment. J Geriatr Oncol. 2021 Nov;12(8):1256-1258. doi: 10.1016/j.jgo.2021.03.013. Epub 2021 Mar 29. PMID: 33795206; PMCID: PMC8478966.
Copy Download .nbib Format: NLM
Share it on

J Geriatr Oncol. 2021 Nov;12(8):1256-1258. doi: 10.1016/j.jgo.2021.03.013. Epub 2021 Mar 29.

Objective performance tests of cognition and physical function as part of a virtual geriatric assessment.

Journal of geriatric oncology

Nupur E Bahl, Emily S Magnavita, Tammy Hshieh, Marcia Testa, Dae Kim, Brad Manor, Jane A Driver, Gregory A Abel, Clark DuMontier

Affiliations

  1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
  2. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Division of Aging, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America.
  3. Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.
  4. Harvard Medical School, Boston, MA, United States of America; Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA, United States of America; Gerontology Division, Beth Israel Deaconess Medical Center, Boston, MA, United States of America.
  5. Division of Aging, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA, United States of America.
  6. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America.
  7. Division of Aging, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA, United States of America. Electronic address: [email protected].

PMID: 33795206 PMCID: PMC8478966 DOI: 10.1016/j.jgo.2021.03.013

[No abstract available.]

Conflict of interest statement

Declaration of Competing Interest None of the authors have any conflicts of interest to disclose. All authors contributed to the design and writing of this letter.

References

  1. JAMA Oncol. 2018 May 1;4(5):686-693 - PubMed
  2. Biomed Sci Instrum. 2014;50:254-64 - PubMed
  3. Z Gerontol Geriatr. 2016 Oct;49(7):581-595 - PubMed
  4. J Geriatr Oncol. 2020 Jun;11(5):761-763 - PubMed
  5. JAMA Intern Med. 2020 Oct 1;180(10):1386-1389 - PubMed
  6. Blood. 2019 Jul 25;134(4):374-382 - PubMed
  7. Digit Biomark. 2019 Apr 30;3(1):22-30 - PubMed
  8. J Geriatr Oncol. 2021 Apr;12(3):473-478 - PubMed
  9. JMIR Mhealth Uhealth. 2018 Jan 30;6(1):e36 - PubMed

Publication Types

Grant support